H1B Salary Data

Home › Occupations › Molecular and Cellular Biologists › Atlanta, GA

Molecular and Cellular Biologists in Atlanta, GA: H-1B salaries

206 labor condition applications for this occupation with a work site in Atlanta, GA. Median offered base salary $70,020; middle half $62,296–$84,130.

Applications (LCAs)206
Median offered salary$70,020
Middle half of salaries$62,296–$84,130
10th–90th percentile$56,597–$108,889

By wage level

Wage levelMedian salary
Level I (entry)$62,450
Level II (qualified)$72,000
Level III (experienced)$87,466
Level IV (fully competent)$105,030

The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.

Employers

EmployerLCAsMedian salary
Emory University129$70,000
Georgia Institute of Technology17$62,400
Georgia State University16$59,000
Centers for Disease Control and Prevention11$87,466
Morehouse School of Medicine10$62,296
Centers for Disease Control and Prevention/dhhs2$99,766
ASRT, Inc.2$82,000
IHRC, Inc.2$125,000
Medical Neurogenetics LLC2$103,000
US Fertility LLC1$105,060
Beckman Coulter, Inc.1$106,296
General Dynamics Information Technology, Inc.1$90,488
Centers Disease Control and Prevention/dhhs1$72,974
Geisinger System Services1$56,597
Geisinger Clinic1$56,597
Meunier Carlin & Curfman LLC1$110,000
Pabst Patent Group LLP1$120,000
Centers for Disease Control and Prevention (CDC)/ DHHS1$76,671
Booz Allen Hamilton Inc.1$182,104
Clark Atlanta University1$63,000
Duke University1$86,488
Eagle Global Scientific, LLC (Bristol Bay Shared Services, LLC)1$124,000
Laboratory Corp of America Holdings1$103,000
Cambium Oncology, LLC1$102,024

Job titles

H-1B sponsors in Atlanta, GA →

Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).